HAE Financial Facts
Total operating expenses: 79.45MNet revenues: 220.25M
See Full Income Statement
Total liabilities and stockholders' equity: 1.33B
Retained earnings: 325.66M
See Full Balance Sheet
Haemonetics Corp. (HAE) Earnings
|
Expand Research on HAE
| Next EPS Date | 11/5/26 | EPS Growth Rate | 0.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.3% | Revenue Growth Rate | +5.5% |
| Average % Move 1-Wk after EPS | +12.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q227 | N/A | $1.27 | N/A | N/A | $344.91M | N/A | N/A | N/A | ||
| 8/6/26 | Q127 | $1.14 | $1.09 | +$0.05 | $339M | $328.92M | N/A |  | | Details | |
| 5/7/26 | Q426 | $1.29 | $1.27 | +$0.02 | $346M | $337.04M | N/A | | | Details | |
| 2/5/26 | Q326 | $1.31 | $1.25 | +$0.06 | $338.97M | $331.91M | = | | | Details | |
| 11/6/25 | Q226 | $1.27 | $1.11 | +$0.16 | $327M | $311.46M | = | | | Details | |
| 8/7/25 | Q126 | $1.10 | $1.01 | +$0.09 | $321.39M | $302.62M | = | | | Details | |
| 5/8/25 | Q425 | $1.24 | $1.22 | +$0.02 | $331M | $330.66M | = | | | Details | |
| 2/6/25 | Q325 | $1.19 | $1.17 | +$0.02 | $349M | $352.98M | = | | | Details |
